trial · primary record
GVV858
Advanced HR+/HER2- Breast Cancer
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 205 |
| Primary completion | 2031-05-09 |
| Primary endpoint | Phase I: Incidence and severity of dose-limiting toxicities (DLTs) |
| Registry ID | NCT07288359 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:54.231Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07288359
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.